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BACKGROUND: 
 
Oesophageal cancer is the sixth most common cancer globally and has a poor prognosis. 
Palliation rather than curative treatment has become the preferred option, and dysphagia is 
a dominant symptom for more than 70% of these patients. 
 
Dysphagia is a difficulty with eating, drinking or swallowing and affects the ability to manage 
oral intake safely, increasing the primary risks of dehydration, malnutrition, aspiration and 
aspiration pneumonia.   
 
Assessed and managed at the pre-oral, oral, oro-pharyngeal and oesophageal stages, 
dysphagia ranges from mild to severe. Non-surgical interventions such as modified food 
textures and fluid consistencies, or changes to posture and positioning, can be used at pre-
oral, oral and oro-pharyngeal stages to achieve positive clinical and quality-of-life outcomes.  
 
Palliative care for patients with advanced oesophageal and gastro-oesophageal carcinoma 
often requires intervention for dysphagia. Dysphagia management at the oesophageal stage 
includes stents, external beam radiation treatment, brachytherapy, chemo-radiotherapy, 
laser treatment and photodynamic therapy. With this abundance of treatment options, there 
is a need for evidence examining the best treatments to improve the management of eating 
and drinking difficulties in this clinical population. 
 
OBJECTIVES: 
 
The review aims to systematically analyse and summarise the efficacy of different 
interventions used in the palliation of dysphagia in primary oesophageal and gastro-
oesophageal carcinoma. This is an update of the previous review published in 2009. 
 
INTERVENTION/METHODS: 
 
The review identified randomised controlled trials where recruitment was based on 
diagnostic criteria: patients with inoperable or unresectable primary oesophageal cancer due 
to undergo palliative treatment, including patients with primary squamous or 
adenocarcinoma of the oesophagus or the gastro-oesophageal junction. Studies with patients 
showing extrinsic oesophageal compression from other tumours, or patients with recurrence 
of dysphagia or recurrence of tumour after previous surgery were excluded.  
 
MAIN ANALYSIS:  
 
Comparing Self-Expanding Metal Stents (SEMS) with plastic stents for dysphagia in 
oesophageal cancer, where the primary outcome was improvement in dysphagia. 
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A wide range of additional interventions were included for cross-comparison, where 
combinations were acceptable if treatments were present in both arms of the study, for 
example chemotherapy, photodynamic therapy (PDT), external beam radiotherapy.  
 
 
PRIMARY OUTCOME:  
 
 Improvement in dysphagia.  
 
 
SECONDARY OUTCOMES:  
 
 dysphagia improvements in subgroups (other interventions) 
 persistent or recurrent dysphagia 
 technical success of the procedure 
 mortality associated with the procedure 
 30-day mortality 
 initial hospital stay 
 all major adverse effects 
 quality of life 
 
The review reports a wide variation in the evaluation and reporting of the different secondary 
outcomes. To compare different brands and models of stents, the review included additional 
outcomes applicable to the subgroup, for example stent migration, degree of concealment, 
reflux score.  
 
RESULTS: 
 
From an initial 785 records, the review identified 53 RCTs, comprising 51 full studies and 2 
abstracts, and involving 3684 patients; the earliest study was published in 1983, with the most 
recent study published in 2013. Assessing bias, the authors considered 47% (n=25) of the 
studies as high quality. 
 
Two studies were used to compare both dysphagia improvement overall and dysphagia 
improvement in the subgroups to analyse the primary outcome. Results are summarised 
below: 
 
Outcome Number of 
Studies 
Number of 
Participants 
Standard 
Mean 
Difference 
Effect Size Quality 
of 
Evidence 
Dysphagia 
improvement 
2 231 -0.36 (-0.63 to -
0.09) 
-0.30  
(-0.69, 0.10) 
Moderat
e 
Subgroup analysis 
dysphagia 
improvement 
2 178  
- 
-0.25  
(-0.50, 0.00) 
Moderat
e 
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For the primary outcome, results show that the traditional insertion of rigid plastic stents is 
less safe and less effective at reducing dysphagia than SEMS, with a high occurrence of 
recurrent dysphagia. In comparison to other modalities, plastic stents are not effective in 
improving dysphagia. 
 
CONCLUSIONS: 
 
SEMS insertion is safe, effective and quicker in palliating dysphagia for this patient group 
when compared to rigid plastic stents. Additional positive outcomes include: 
 
 High-dose intraluminal brachytherapy is a suitable alternative to SEMS insertion, with 
fewer requirements for re-intervention, and might provide additional survival benefit 
with a better quality of life 
 Some anti-reflux stents and newly-designed stents lead to longer survival and fewer 
complications compared to conventional stents 
 Combined brachytherapy and SEMS insertion reduce the requirement for re-
intervention 
 Combined brachytherapy and radiotherapy reduce the requirement for re-
intervention 
 
The following interventions show a high incidence of delayed complications and recurrent 
dysphagia, and are not recommended: 
 
 Rigid plastic stent insertion 
 Dilatation alone or combined with other interventions 
 Chemotherapy alone 
 
Regarding quality of life, there is no superiority of one intervention over another, although 
the authors suggest that different combinations of treatments could produce better 
outcomes and fewer complications.  
 
IMPLICATIONS FOR PRACTICE: 
 
Results are relevant for nurse specialists working in gastroenterology, oncology and palliative 
care services, as well as nursing teams working with Radiotherapy, Speech and Language 
Therapy, Clinical Nutrition and Dietetics services. This review of non-curative interventions 
contributes to high-quality perioperative support and palliative care standards.  
 
This review gives support to the provision of evidence-based information for patients and 
their families. Understanding the risks and complications of interventions enables clearer 
aims and personalised post-surgical care when managing mealtimes and dysphagia for these 
patients, within palliative care guidelines. Evidence for interventions and their outcomes 
supports risk assessments for maintaining oral intake. In addition, this report identifies 
procedures with an increased risk of immediate and delayed complications. 
 
Further studies are required to address the timing of intervention and the cost effectiveness 
of interventions. The review lists a number of newly-designed, newly-available stents on the 
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market and acknowledges that advances in design and technology are likely to result in 
improved outcomes for this patient group undergoing treatment in the future. However, 
quality of life outcome measures following SEMS insertion need further investigation to 
ensure that treatments produce positive outcomes for patients and families.  
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